Considering our finding of hsa-miR-144-5p targeting CUL3, its downregulation leads to increased NFR2 activity [46] a potential novel target for AD treatment due to its antioxidant capacity and role in memory and synaptic plasticity protection [47]. This evidence concerns the gene CUL3 and Alzheimer disease.